Advertisement

Topics

Molecular Nanosystems, Inc. Company Profile

12:28 EDT 19th September 2018 | BioPortfolio

Molecular Nanosystems, Inc. was co-founded in 2001 by Dr. Hongjie Dai, an Associate Professor at Stanford University and world-renowned scholar and scientist in the field of nanotechnology. Headquartered in Palo Alto, CA, the company is using its leading-edge, patent-protected site-selective chemical vapor deposition technology to develop solutions for the field of electronics.

Location

977 Commercial Street
Palo Alto
California
94303
United States of America

Contact

Phone: 650-846-2519
Fax: 650-846-2522
Email: info@monano.com


News Articles [462 Associated News Articles listed on BioPortfolio]

Precision NanoSystems Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09052018] Prices from USD $250

SummaryPrecision NanoSystems Inc Precision NanoSystems is a biopharmaceutical company that provides nanotechnology solutions to manufacture nanoparticles for molecular understanding and treatment of d...

Precision NanoSystems Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryPrecision NanoSystems Inc Precision NanoSystems develops innovative systems and nanotechnology solutions to manufacture nanoparticles for molecular understanding and treatment of disease. The c...

The Molecular Autopsy: Not Ready Yet for Prime Time

Although I have always been a strong advocate for sophisticated molecular and genomic testing, I tend to get a severe case of indigestion when I see references to the molecular autopsy (see: Can Inter...

Molecular Health introduces MH Mendel to help geneticists in diagnosing hereditary diseases

Molecular Health, a leading biomedical company that is transforming molecular data into clinically actionable information for efficient and safer cancer treatment options based on its proprietary Data...

Precision Nanosystems NanoAssemblr series microfluidic-based nanoparticle manufacturing platform

While nanoparticles, composed of polymers or lipids, can be used to deliver pharmaceutical drugs, they are traditionally made by extrusion or sonication — which can be labour-intensive and prone to ...

One Type Of Data Is Not Enough In Personalized Medicine

ArticleThe big challenge in cancer is that each patient's disease is different from a molecular point of view and has a unique set of molecular features that have led to its development, according to ...

Molecular switches are not just 'on' or 'off'

(Aarhus University) It is not always easy to see if a switch is on or off! A new study shows that the same can be true of a molecular switch. This knowledge gives a new insight into the molecular swit...

New Molecular Wires for Single-Molecule Electronic Devices

NewsScientists have designed a new type of molecular wire doped with organometallic ruthenium to achieve unprecedentedly higher conductance than earlier molecular wires.

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Salsalate [Libertas Pharma, Inc.]

Salsalate Tablets, USP 500 and 750 mgRx Only

PubMed Articles [622 Associated PubMed Articles listed on BioPortfolio]

Nanosystems in Edible Coatings: A Novel Strategy for Food Preservation.

Currently, nanotechnology represents an important tool and an efficient option for extending the shelf life of foods. Reducing particle size to nanometric scale gives materials distinct and improved p...

Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics.

There is an increasing demand to develop effective methods for treating malignant diseases to improve healthcare in our society. Stimuli-responsive nanosystems, which can respond to internal or extern...

Development and Evaluation of Stimuli-Responsive Chimeric Nanostructures.

Chimeric/mixed stimuli-responsive nanocarriers are promising agents for therapeutic and diagnostic applications, as well as in the combinatorial field of theranostics. Herein, we designed chimeric nan...

Micro/nanostructured inhalable formulation based on polysaccharides: Effect of a thermoprotectant on powder properties and protein integrity.

Combined micro- and nanosystems are appealing for pulmonary protein delivery, fulfilling the specific physiological requirements for efficient outcomes in-vivo. However, fabrication of protein formula...

Biological Stimulus-Driven Assembly/Disassembly of Functional Nanoparticles for Targeted Delivery, Controlled Activation, and Bioelimination.

Nanoassembly technology has emerged as a powerful tool for targeted drug delivery and provides a basis for fabricating medical theranostic nanosystems. However, it is extremely difficult to concentrat...

Clinical Trials [1311 Associated Clinical Trials listed on BioPortfolio]

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

In Vivo EGFR Molecular Classification

The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Validation of a Molecular Prognostic Test for Eye Melanoma

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detect...

LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

This is a pilot feasibility study assessing the use of a commercial molecular profiling service in the UK's National Health Service (NHS). The impact of knowledge of a patient's molecular ...

Companies [851 Associated Companies listed on BioPortfolio]

Molecular Nanosystems, Inc.

Molecular Nanosystems, Inc. was co-founded in 2001 by Dr. Hongjie Dai, an Associate Professor at Stanford University and world-renowned scholar and scientist in the field of nanotechnology. Headquarte...

Precision NanoSystems

Precision NanoSystems Inc. (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. P...

ABT Molecular Imaging

ABT Molecular Imaging is a medical imaging company marketing its Generator, a production platform which produces unit doses of molecular imaging drugs for positron emission tomogr...

Magnify

Magnify, the California NanoSystems Institute (CNSI) incubator, accelerates the growth and success of transformative technology startups in the greater Los Angeles area by providi...

HTG Molecular Diagnostics

HTG Molecular Diagnostics is a leading provider of molecular-based solutions for gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic appli...

More Information about "Molecular Nanosystems, Inc." on BioPortfolio

We have published hundreds of Molecular Nanosystems, Inc. news stories on BioPortfolio along with dozens of Molecular Nanosystems, Inc. Clinical Trials and PubMed Articles about Molecular Nanosystems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Nanosystems, Inc. Companies in our database. You can also find out about relevant Molecular Nanosystems, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record